Guidelines for Poster Presenters
15 – 17 August 2025
Singapore EXPO
CONTACT
Kenes MP Asia Pte Ltd
15 – 17 August 2025
Singapore EXPO
Kenes MP Asia Pte Ltd
Prof Yugeesh Lankadeva
Professor Yugeesh Lankadeva is a National Health and Medical Research Council Emerging Leader Fellow and a National Heart Foundation Future-Leader Fellow and leads the Critical Care Research Department at the Florey Institute of Neuroscience and Mental Health. His research aims to understand the pathophysiology of brain and kidney injury arising from sepsis and cardiac surgery requiring cardiopulmonary bypass. Armed with this knowledge, he hopes to develop novel diagnostics and therapeutics to improve patient-centred health outcomes.
Professor Lankadeva has over 70 publications in high-impact medical journals. The quality and clinical relevance of his work has been acknowledged by the award of more than $30 million in competitive research funding. His discoveries have translated to 10 clinical trials across Australia, Europe, US and Asia.
He is an inventor on 3 patents and has received over 30 prestigious career awards. Professor Lankadeva currently holds appointments as Chief Scientific Officer of PanAscea Pty Ltd, Managing Director of CREDOS-BIOTECH Pty Ltd, Senior Principal Honorary Research Fellow at the Department of Critical Care, Melbourne Medical School, University of Melbourne and Senior Principal Honorary Research Fellow at the Department of Anaesthesia, Austin Hospital.
Prof Sheila Nainan Myatra
Sheila Myatra is a Professor of Anaesthesiology and Critical Care, working at the Tata Memorial Hospital in Mumbai, India ( largest cancer centre in Asia). She is the Chair of the Intensive & Critical Care Medicine Committee of the World Federation of Societies of Anaesthesiologists (WFSA) and the Immediate President of the Indian Society of Critical Care Medicine (ISCCM). She is the Past President of the All India Difficult Airway Association (AIDAA).
She is a member of the Surviving Sepsis Campaign (SCC) 2025 Guidelines and SSC Research Committee, and the Steering Committee Member of the Asia Pacific Sepsis Alliance (APSA). She is among the 14 international airway experts on the American Society of Anesthesiologists (ASA) difficult airway guidelines and the PUMA guidelines (Project for the Universal Management of the Airway). Her research interests include hemodynamic monitoring, airway management and sepsis. She has developed a new test in hemodynamic monitoring, called the “tidal volume challenge” (CCM 2017).
She was awarded the prestigious 2023 ESICM Honorary Membership at ESICM Lives in Milan and the European Airway Management Society (EAMS) Honorary Membership in 2022. Awarded FCCM (American College of CCM) and FICCM by ISCCM. She delivered the William C Shoemaker Honorary Lecture at SCCM 2023 in San Francisco, USA. She serves on the Editorial Board of several journals including Anaesthesia, Canadian Journal of Anaesthesia, Journal of Critical Care, Critical Care Science, Anaesthesia Critical Care & Pain Medicine, Trends in Anaesthesia and Critical Care, Journal of Anaesthesiology Clinical Pharmacology, Indian Journal of Anaesthesiology and Intensive Care Medicine (past Editorial Board member). She has several publications to her credit.
Prof Sandroni Claudio
Claudio Sandroni is professor of Intensive Care at the Catholic University School of Medicine in Rome, Italy. He is responsible for post-cardiac arrest management in a 19-bed Intensive Care Unit and conducts research on hypoxic-ischaemic brain injury (HIBI) and post-resuscitation care.
Since 2013, Dr Sandroni is leading an expert group reviewing evidence on the severity of HIBI. This work informed the 2015 and 2021 Post-Resuscitation Care Guidelines from the European Society of Intensive Care Medicine (ESICM) and the European Resuscitation Council (ERC).
Within the International Liaison Committee on Resuscitation (ILCOR) Dr Sandroni participates in the continuous evidence evaluation process that ILCOR conducts to disseminate evidence-informed resuscitation science and treatment recommendations in the World. He serves as member of the ILCOR Advanced Life Support (ALS) task Force and the Science Advisory Committee.
Dr Sandroni is the past Chair of the Trauma and Emergency Medicine (TEM) Section of ESICM and member of the Editorial Board of Intensive Care Medicine, and Resuscitation, official Journals of ESICM and ERC, respectively. He is fellow of the ERC and the American Heart Association.
To date, Dr Claudio Sandroni authored 225 publications, cited 15,794 times. His h-index is 55 (source: Scopus)
Prof Rinaldo Bellomo
Prof Bellomo is Professor of Intensive Care Medicine, University of Melbourne, Honorary Professor of Medicine, Monash University, Co-director of the Australian and New Zealand Intensive Care Research Centre. He has produced >1900 PubMed cited publications and is the most published biomedical investigator in the history of Australian medicine. Since 2006, he has been the most published intensive care investigator in the world (>100 per annum for the past 10 years).
Prof Paul Young
Paul Young is an intensive care specialist and clinical researcher from Wellington, New Zealand. He is the Co-clinical Leader at Wellington Hospital ICU and a Deputy Director at the Medical Research Institute of New Zealand. His research interests include everything related to intensive care medicine. He has almost 300 publications in peer-reviewed journals including more than 20 in the worlds’ highest impact medical journals (the New England Journal of Medicine, JAMA, and the Lancet). He is the Chief Investigator for the Mega-ROX trial, a 40,000-participant randomised clinical trial evaluating oxygen therapy regimens in ICU patients who require unplanned life support. The Mega-ROX trial will finish recruitment in the 2nd half of 2025 and is currently enrolling around 1000 patients per month in 130 ICUs in 14 countries. Paul’s research is supported by funding from the Health Research Council of New Zealand.
Prof Carol Hodgson
Professor Carol Hodgson is a clinical trialist with particular expertise in long-term outcomes after critical illness. She leads, as Executive Director, Monash Partners Academic Health Science Centre, which aims to ensure research is implemented and translated into healthcare to improve patient outcomes. She is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University. She has worked in ICU at Alfred Health for over 25 years where she is a Specialist Physiotherapist.
Prof Alexandre T. Rotta
Alexandre Rotta, MD, FCCM is a Professor of Pediatrics at Duke University School of Medicine, in Durham, NC. He is the Chief of the Division of Pediatric Critical Care Medicine, and Executive Co-Director of the Pediatric and Congenital Heart Center at Duke University Medical Center/ Duke Children’s Hospital. Dr. Rotta is a Fellow of the American College of Critical Care and is a former Chair of the Pediatric Section of the Society of Critical Care Medicine (SCCM). He is Senior Co-Editor of the current edition of the “Fuhrman and Zimmerman Pediatric Critical Care Medicine” textbook and has published extensively in the field of pediatric critical care. His academic interests include acute respiratory failure, advanced modalities of respiratory support, cardiac intensive care, bronchiolitis and critical asthma, and medical emergencies in commercial aviation.
Dr Zhang Zhongheng
Dr. Zhongheng is a Chief Physician, Associate Professor, and Distinguished Researcher. He serves as the Deputy Director of the Department of Emergency Medicine at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, and the Deputy Director of the Institute of Emergency Medicine at Zhejiang University School of Medicine. Dr. Zhongheng’s research program is focused on advancing precision treatment for critically ill adults, aiming to address the significant heterogeneity observed in critical illnesses such as sepsis, acute respiratory distress syndrome, and multi-organ failure. He has published more than 50 peer-reviewed papers in prestigious journals such as Nature Communications, Intensive Care Medicine, and eClinicalMedicine. He has received several research grants from the National Science Foundation of China and the Ministry of Science and Technology of the People’s Republic of China.
Dr Olive Pei Ee Lee
Dr Olive Lee is a paediatric intensivist trained in Malaysia and the United Kingdom. Her passion is advancing paediatric intensive care in Malaysia, to help the critically ill children receive the care they need.
She obtained her fellowship in paediatric critical care in Malaysia and Birmingham Children’s Hospital, with a special interest in incorporating point of care ultrasound in intensive care management. She is one of the few paediatric intensivists in Malaysia actively involved in training doctors point of care ultrasound.
Her other interests include education and training of junior paediatric doctors with a focus on managing paediatric emergencies.
She is passionate in research, her focus being management of sepsis and extracorporeal therapy. She participated in various studies and published several peer-reviewed articles in paediatric critical care.
True to her “less is more” approach in intensive care, she aspires to develop a holistic intensive care unit in a resource limited setting, to demonstrate that every sick kid can still be managed in resource-poor centres.
Dr Glenn Eastwood
Dr Glenn Eastwood is the Intensive Care Research Manager at the Austin Hospital and an Adjunct Senior Research Fellow in the School of Public Health and Preventive Medicine at Monash University. Through teamwork and collaboration, he is one of Australia’s most experienced and successful Intensive Care nurse researchers.
Dr Eastwood was the Chief Principal Investigator of the NEJM published Targeted Therapeutic Mild Hypercapnia After Resuscitated Cardiac Arrest randomised controlled trial (TAME Cardiac Arrest Trial). He holds a Research Doctorate (PhD) with Deakin University in research dedicated to oxygen therapy for patients at risk of respiratory dysfunction. His research program is focused on the impact and outcome of gas management (oxygen and carbon dioxide) in critically ill patients and he has published widely in this area.
Dr Dileep Raman
Dileep Raman is the Co-founder and Chief of Healthcare at Cloudphysician, a company revolutionising healthcare delivery through technology-augmented solutions. He leads clinical excellence, overseeing clinical operations and product innovation.
With a mission to empower both patients and providers, Dileep focuses on integrating technology designed for real-world constraints. Under his leadership, Cloudphysician has secured three patents and continues to innovate in healthcare technology focusing on domain specific computer vision models.
He completed his Internal Medicine residency at Texas Tech University, USA, serving as Chief Resident, and later trained as a Pulmonary, Critical Care, and Sleep Medicine fellow at the Cleveland Clinic Foundation, where he also served as Chief Fellow.
In 2015, he returned to India with his co-founder to build Cloudphysician, driven by a vision to enhance healthcare quality and provider experience through cutting-edge solutions.
A/Prof Mark Plummer
Associate Professor Mark Plummer is an NHMRC Emerging Leader Fellow and Head of Research and Innovation at the Royal Adelaide Hospital ICU. He was the scientific convenor for the APICS meeting in 2022 and is thrilled to be back in Singapore. His research interests include dysglycaemia, neurocritical care, sepsis and developing clinically relevant pre-clinical models of critical illness.
Please be aware of fraudulent websites, companies and individuals that link to the APICS that offer registrations, hotel bookings and other services. APICS does not accept any responsibility for bookings made via unofficial websites/agencies or any money lost as a result. This website is the official and only APICS 2025 Symposium Registration Page.